Skip to main content
PMC home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1998 May 1;101(9):1827–1834. doi: 10.1172/JCI1709

Hepatocyte growth factor prevents renal fibrosis and dysfunction in a mouse model of chronic renal disease.

S Mizuno 1, T Kurosawa 1, K Matsumoto 1, Y Mizuno-Horikawa 1, M Okamoto 1, T Nakamura 1
PMCID: PMC508767  PMID: 9576745

Abstract

Chronic renal disease (CRD) is generally thought to be incurable, except through renal transplantation, and the number of patients with CRD is on the increase. Glomerulosclerosis and tubulointerstitial fibrosis represent the morphological equivalent of end-stage CRD. In this study, we demonstrated the preventive effect of hepatocyte growth factor (HGF) on the progression of renal dysfunction and fibrosis, using a spontaneous mouse model for CRD (ICGN strain). The mice progressively developed glomerular sclerotic injury, tubular atrophy, and renal dysfunction until they were 17 wk of age. When recombinant HGF was injected into these mice during a 4-wk-period (from weeks 14-17 after birth), DNA synthesis of tubular epithelial cells was found to be 4.4-fold higher than in mice without HGF injection, thereby suggesting tubular parenchymal expansion promoted by HGF. Notably, HGF suppressed the expression of transforming growth factor-beta and of platelet-derived growth factor as well as myofibroblast formation in the affected kidney. Consequently, the onset of tubulointerstitial fibrosis was almost completely inhibited by HGF, while HGF attenuated the progression of glomerulosclerosis, both leading to preventing manifestation of renal dysfunction. From our results, supplement therapy with HGF may be taken into consideration as a novel option for prevention and treatment of CRD.

Full Text

The Full Text of this article is available as a PDF (635.5 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Alpers C. E., Hudkins K. L., Floege J., Johnson R. J. Human renal cortical interstitial cells with some features of smooth muscle cells participate in tubulointerstitial and crescentic glomerular injury. J Am Soc Nephrol. 1994 Aug;5(2):201–209. doi: 10.1681/ASN.V52201. [DOI] [PubMed] [Google Scholar]
  2. Barros E. J., Santos O. F., Matsumoto K., Nakamura T., Nigam S. K. Differential tubulogenic and branching morphogenetic activities of growth factors: implications for epithelial tissue development. Proc Natl Acad Sci U S A. 1995 May 9;92(10):4412–4416. doi: 10.1073/pnas.92.10.4412. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Bohle A., Strutz F., Müller G. A. On the pathogenesis of chronic renal failure in primary glomerulopathies: a view from the interstitium. Exp Nephrol. 1994 Jul-Aug;2(4):205–210. [PubMed] [Google Scholar]
  4. Border W. A., Noble N. A. Transforming growth factor beta in tissue fibrosis. N Engl J Med. 1994 Nov 10;331(19):1286–1292. doi: 10.1056/NEJM199411103311907. [DOI] [PubMed] [Google Scholar]
  5. Brenner B. M., Meyer T. W., Hostetter T. H. Dietary protein intake and the progressive nature of kidney disease: the role of hemodynamically mediated glomerular injury in the pathogenesis of progressive glomerular sclerosis in aging, renal ablation, and intrinsic renal disease. N Engl J Med. 1982 Sep 9;307(11):652–659. doi: 10.1056/NEJM198209093071104. [DOI] [PubMed] [Google Scholar]
  6. Eddy A. A. Molecular insights into renal interstitial fibrosis. J Am Soc Nephrol. 1996 Dec;7(12):2495–2508. doi: 10.1681/ASN.V7122495. [DOI] [PubMed] [Google Scholar]
  7. Floege J., Johnson R. J., Gordon K., Iida H., Pritzl P., Yoshimura A., Campbell C., Alpers C. E., Couser W. G. Increased synthesis of extracellular matrix in mesangial proliferative nephritis. Kidney Int. 1991 Sep;40(3):477–488. doi: 10.1038/ki.1991.235. [DOI] [PubMed] [Google Scholar]
  8. Hostetter T. H. Progression of renal disease and renal hypertrophy. Annu Rev Physiol. 1995;57:263–278. doi: 10.1146/annurev.ph.57.030195.001403. [DOI] [PubMed] [Google Scholar]
  9. Igawa T., Kanda S., Kanetake H., Saitoh Y., Ichihara A., Tomita Y., Nakamura T. Hepatocyte growth factor is a potent mitogen for cultured rabbit renal tubular epithelial cells. Biochem Biophys Res Commun. 1991 Jan 31;174(2):831–838. doi: 10.1016/0006-291x(91)91493-v. [DOI] [PubMed] [Google Scholar]
  10. Isaka Y., Brees D. K., Ikegaya K., Kaneda Y., Imai E., Noble N. A., Border W. A. Gene therapy by skeletal muscle expression of decorin prevents fibrotic disease in rat kidney. Nat Med. 1996 Apr;2(4):418–423. doi: 10.1038/nm0496-418. [DOI] [PubMed] [Google Scholar]
  11. Isaka Y., Fujiwara Y., Ueda N., Kaneda Y., Kamada T., Imai E. Glomerulosclerosis induced by in vivo transfection of transforming growth factor-beta or platelet-derived growth factor gene into the rat kidney. J Clin Invest. 1993 Dec;92(6):2597–2601. doi: 10.1172/JCI116874. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Ishibashi K., Sasaki S., Sakamoto H., Nakamura Y., Hata T., Nakamura T., Marumo F. Hepatocyte growth factor is a paracrine factor for renal epithelial cells: stimulation of DNA synthesis and NA,K-ATPase activity. Biochem Biophys Res Commun. 1992 Jan 31;182(2):960–965. doi: 10.1016/0006-291x(92)91825-b. [DOI] [PubMed] [Google Scholar]
  13. Ishiki Y., Ohnishi H., Muto Y., Matsumoto K., Nakamura T. Direct evidence that hepatocyte growth factor is a hepatotrophic factor for liver regeneration and has a potent antihepatitis effect in vivo. Hepatology. 1992 Nov;16(5):1227–1235. [PubMed] [Google Scholar]
  14. Joannidis M., Spokes K., Nakamura T., Faletto D., Cantley L. G. Regional expression of hepatocyte growth factor/c-met in experimental renal hypertrophy and hyperplasia. Am J Physiol. 1994 Aug;267(2 Pt 2):F231–F236. doi: 10.1152/ajprenal.1994.267.2.F231. [DOI] [PubMed] [Google Scholar]
  15. Johnson R. J., Raines E. W., Floege J., Yoshimura A., Pritzl P., Alpers C., Ross R. Inhibition of mesangial cell proliferation and matrix expansion in glomerulonephritis in the rat by antibody to platelet-derived growth factor. J Exp Med. 1992 May 1;175(5):1413–1416. doi: 10.1084/jem.175.5.1413. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Kawaida K., Matsumoto K., Shimazu H., Nakamura T. Hepatocyte growth factor prevents acute renal failure and accelerates renal regeneration in mice. Proc Natl Acad Sci U S A. 1994 May 10;91(10):4357–4361. doi: 10.1073/pnas.91.10.4357. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Kliem V., Johnson R. J., Alpers C. E., Yoshimura A., Couser W. G., Koch K. M., Floege J. Mechanisms involved in the pathogenesis of tubulointerstitial fibrosis in 5/6-nephrectomized rats. Kidney Int. 1996 Mar;49(3):666–678. doi: 10.1038/ki.1996.95. [DOI] [PubMed] [Google Scholar]
  18. Knecht A., Fine L. G., Kleinman K. S., Rodemann H. P., Müller G. A., Woo D. D., Norman J. T. Fibroblasts of rabbit kidney in culture. II. Paracrine stimulation of papillary fibroblasts by PDGF. Am J Physiol. 1991 Aug;261(2 Pt 2):F292–F299. doi: 10.1152/ajprenal.1991.261.2.F292. [DOI] [PubMed] [Google Scholar]
  19. Laurens W., Battaglia C., Foglieni C., De Vos R., Malanchini B., Van Damme B., Vanrenterghem Y., Remuzzi G., Remuzzi A. Direct podocyte damage in the single nephron leads to albuminuria in vivo. Kidney Int. 1995 Apr;47(4):1078–1086. doi: 10.1038/ki.1995.154. [DOI] [PubMed] [Google Scholar]
  20. Lloyd C. M., Minto A. W., Dorf M. E., Proudfoot A., Wells T. N., Salant D. J., Gutierrez-Ramos J. C. RANTES and monocyte chemoattractant protein-1 (MCP-1) play an important role in the inflammatory phase of crescentic nephritis, but only MCP-1 is involved in crescent formation and interstitial fibrosis. J Exp Med. 1997 Apr 7;185(7):1371–1380. doi: 10.1084/jem.185.7.1371. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Matsuda Y., Matsumoto K., Ichida T., Nakamura T. Hepatocyte growth factor suppresses the onset of liver cirrhosis and abrogates lethal hepatic dysfunction in rats. J Biochem. 1995 Sep;118(3):643–649. doi: 10.1093/oxfordjournals.jbchem.a124958. [DOI] [PubMed] [Google Scholar]
  22. Matsuda Y., Matsumoto K., Yamada A., Ichida T., Asakura H., Komoriya Y., Nishiyama E., Nakamura T. Preventive and therapeutic effects in rats of hepatocyte growth factor infusion on liver fibrosis/cirrhosis. Hepatology. 1997 Jul;26(1):81–89. doi: 10.1053/jhep.1997.v26.pm0009214455. [DOI] [PubMed] [Google Scholar]
  23. Miller S. B., Martin D. R., Kissane J., Hammerman M. R. Hepatocyte growth factor accelerates recovery from acute ischemic renal injury in rats. Am J Physiol. 1994 Jan;266(1 Pt 2):F129–F134. doi: 10.1152/ajprenal.1994.266.1.F129. [DOI] [PubMed] [Google Scholar]
  24. Miyazawa K., Tsubouchi H., Naka D., Takahashi K., Okigaki M., Arakaki N., Nakayama H., Hirono S., Sakiyama O., Takahashi K. Molecular cloning and sequence analysis of cDNA for human hepatocyte growth factor. Biochem Biophys Res Commun. 1989 Sep 15;163(2):967–973. doi: 10.1016/0006-291x(89)92316-4. [DOI] [PubMed] [Google Scholar]
  25. Mizuno S., Yue B. F., Okamoto M., Horikawa Y., Kurosawa T. Diffuse glomerulosclerosis without tubular injury does not directly manifest renal dysfunction in nephrotic mice (ICGN strain). Exp Nephrol. 1997 Nov-Dec;5(6):498–507. [PubMed] [Google Scholar]
  26. Montesano R., Matsumoto K., Nakamura T., Orci L. Identification of a fibroblast-derived epithelial morphogen as hepatocyte growth factor. Cell. 1991 Nov 29;67(5):901–908. doi: 10.1016/0092-8674(91)90363-4. [DOI] [PubMed] [Google Scholar]
  27. Morishita R., Nakamura S., Nakamura Y., Aoki M., Moriguchi A., Kida I., Yo Y., Matsumoto K., Nakamura T., Higaki J. Potential role of an endothelium-specific growth factor, hepatocyte growth factor, on endothelial damage in diabetes. Diabetes. 1997 Jan;46(1):138–142. doi: 10.2337/diab.46.1.138. [DOI] [PubMed] [Google Scholar]
  28. Nagaike M., Hirao S., Tajima H., Noji S., Taniguchi S., Matsumoto K., Nakamura T. Renotropic functions of hepatocyte growth factor in renal regeneration after unilateral nephrectomy. J Biol Chem. 1991 Dec 5;266(34):22781–22784. [PubMed] [Google Scholar]
  29. Nakamura T., Nishizawa T., Hagiya M., Seki T., Shimonishi M., Sugimura A., Tashiro K., Shimizu S. Molecular cloning and expression of human hepatocyte growth factor. Nature. 1989 Nov 23;342(6248):440–443. doi: 10.1038/342440a0. [DOI] [PubMed] [Google Scholar]
  30. Ogura A., Asano T., Suzuki O., Yamamoto Y., Noguchi Y., Kawaguchi H., Yamaguchi Y. Hereditary nephrotic syndrome with progression to renal failure in a mouse model (ICGN strain): clinical study. Nephron. 1994;68(2):239–244. doi: 10.1159/000188264. [DOI] [PubMed] [Google Scholar]
  31. Ong A. C., Fine L. G. Loss of glomerular function and tubulointerstitial fibrosis: cause or effect? Kidney Int. 1994 Feb;45(2):345–351. doi: 10.1038/ki.1994.44. [DOI] [PubMed] [Google Scholar]
  32. Raij L., Azar S., Keane W. Mesangial immune injury, hypertension, and progressive glomerular damage in Dahl rats. Kidney Int. 1984 Aug;26(2):137–143. doi: 10.1038/ki.1984.147. [DOI] [PubMed] [Google Scholar]
  33. Risdon R. A., Sloper J. C., De Wardener H. E. Relationship between renal function and histological changes found in renal-biopsy specimens from patients with persistent glomerular nephritis. Lancet. 1968 Aug 17;2(7564):363–366. doi: 10.1016/s0140-6736(68)90589-8. [DOI] [PubMed] [Google Scholar]
  34. Shima N., Tsuda E., Goto M., Yano K., Hayasaka H., Ueda M., Higashio K. Hepatocyte growth factor and its variant with a deletion of five amino acids are distinguishable in their biological activity and tertiary structure. Biochem Biophys Res Commun. 1994 Apr 29;200(2):808–815. doi: 10.1006/bbrc.1994.1523. [DOI] [PubMed] [Google Scholar]
  35. Shiota G., Wang T. C., Nakamura T., Schmidt E. V. Hepatocyte growth factor in transgenic mice: effects on hepatocyte growth, liver regeneration and gene expression. Hepatology. 1994 Apr;19(4):962–972. [PubMed] [Google Scholar]
  36. Sonnenberg E., Meyer D., Weidner K. M., Birchmeier C. Scatter factor/hepatocyte growth factor and its receptor, the c-met tyrosine kinase, can mediate a signal exchange between mesenchyme and epithelia during mouse development. J Cell Biol. 1993 Oct;123(1):223–235. doi: 10.1083/jcb.123.1.223. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Takayama H., LaRochelle W. J., Sabnis S. G., Otsuka T., Merlino G. Renal tubular hyperplasia, polycystic disease, and glomerulosclerosis in transgenic mice overexpressing hepatocyte growth factor/scatter factor. Lab Invest. 1997 Aug;77(2):131–138. [PubMed] [Google Scholar]
  38. Takehara T., Matsumoto K., Nakamura T. Cell density-dependent regulation of albumin synthesis and DNA synthesis in rat hepatocytes by hepatocyte growth factor. J Biochem. 1992 Sep;112(3):330–334. doi: 10.1093/oxfordjournals.jbchem.a123900. [DOI] [PubMed] [Google Scholar]
  39. Tang W. W., Ulich T. R., Lacey D. L., Hill D. C., Qi M., Kaufman S. A., Van G. Y., Tarpley J. E., Yee J. S. Platelet-derived growth factor-BB induces renal tubulointerstitial myofibroblast formation and tubulointerstitial fibrosis. Am J Pathol. 1996 Apr;148(4):1169–1180. [PMC free article] [PubMed] [Google Scholar]
  40. Woolf A. S., Kolatsi-Joannou M., Hardman P., Andermarcher E., Moorby C., Fine L. G., Jat P. S., Noble M. D., Gherardi E. Roles of hepatocyte growth factor/scatter factor and the met receptor in the early development of the metanephros. J Cell Biol. 1995 Jan;128(1-2):171–184. doi: 10.1083/jcb.128.1.171. [DOI] [PMC free article] [PubMed] [Google Scholar]
  41. Yaekashiwa M., Nakayama S., Ohnuma K., Sakai T., Abe T., Satoh K., Matsumoto K., Nakamura T., Takahashi T., Nukiwa T. Simultaneous or delayed administration of hepatocyte growth factor equally represses the fibrotic changes in murine lung injury induced by bleomycin. A morphologic study. Am J Respir Crit Care Med. 1997 Dec;156(6):1937–1944. doi: 10.1164/ajrccm.156.6.9611057. [DOI] [PubMed] [Google Scholar]
  42. Yasuda H., Imai E., Shiota A., Fujise N., Morinaga T., Higashio K. Antifibrogenic effect of a deletion variant of hepatocyte growth factor on liver fibrosis in rats. Hepatology. 1996 Sep;24(3):636–642. doi: 10.1053/jhep.1996.v24.pm0008781336. [DOI] [PubMed] [Google Scholar]
  43. Yo Y., Morishita R., Yamamoto K., Tomita N., Kida I., Hayashi S., Moriguchi A., Kato S., Matsumoto K., Nakamura T. Actions of hepatocyte growth factor as a local modulator in the kidney: potential role in pathogenesis of renal disease. Kidney Int. 1998 Jan;53(1):50–58. doi: 10.1046/j.1523-1755.1998.00726.x. [DOI] [PubMed] [Google Scholar]
  44. Zarnegar R., Michalopoulos G. K. The many faces of hepatocyte growth factor: from hepatopoiesis to hematopoiesis. J Cell Biol. 1995 Jun;129(5):1177–1180. doi: 10.1083/jcb.129.5.1177. [DOI] [PMC free article] [PubMed] [Google Scholar]
  45. el Nahas A. M., Muchaneta-Kubara E. C., Zhang G., Adam A., Goumenos D. Phenotypic modulation of renal cells during experimental and clinical renal scarring. Kidney Int Suppl. 1996 May;54:S23–S27. [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES